Prospects in the immunological treatment of rheumatoid arthritis.
D000728:Androgens / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D003524:Cyclosporins / Q000627:therapeutic use; D005260:Female; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D008297:Male; D051379:Mice; D008814:Mice, Inbred NZB; D011257:Pregnancy Proteins / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D013951:Thymus Hormones / Q000627:therapeutic use
D000728:Androgens; D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D011257:Pregnancy Proteins; D013951:Thymus Hormones